XERIS PHARMACEUTICALS INC's ticker is and the CUSIP is 98422LAA5. A total of 6 filers reported holding XERIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,212 | -10.4% | 11,500,000 | 0.0% | 0.02% | 0.0% |
| Q2 2023 | $12,519 | +32.6% | 11,500,000 | +9.5% | 0.02% | +25.0% |
| Q1 2023 | $9,439 | +8.9% | 10,500,000 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $8,668 | -99.9% | 10,500,000 | 0.0% | 0.01% | -14.3% |
| Q3 2022 | $9,802,000 | +2.9% | 10,500,000 | 0.0% | 0.01% | +7.7% |
| Q2 2022 | $9,526,000 | -21.4% | 10,500,000 | 0.0% | 0.01% | -7.1% |
| Q1 2022 | $12,123,000 | -6.8% | 10,500,000 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $13,013,000 | +4.6% | 10,500,000 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $12,446,000 | -20.7% | 10,500,000 | +5.0% | 0.01% | -22.2% |
| Q2 2021 | $15,687,000 | -12.9% | 10,000,000 | -5.9% | 0.02% | -18.2% |
| Q1 2021 | $18,010,000 | +30.2% | 10,625,000 | +34.9% | 0.02% | +29.4% |
| Q4 2020 | $13,836,000 | +78.2% | 7,875,000 | +96.9% | 0.02% | +54.5% |
| Q3 2020 | $7,763,000 | +124.0% | 4,000,000 | +14.3% | 0.01% | +120.0% |
| Q2 2020 | $3,466,000 | – | 3,500,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kamunting Street Capital Management, L.P. | 1,500 | $1,508,000 | 1.72% |
| Context Capital Management, LLC | 3,250,000 | $3,202,000 | 1.24% |
| Mohican Financial Management, LLC | 500,000 | $494,000 | 0.89% |
| 683 Capital Management, LLC | 10,000,000 | $10,050,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 18,000,000 | $17,732,000 | 0.52% |
| SILVERBACK ASSET MANAGEMENT LLC | 1,500,000 | $1,496,000 | 0.37% |
| Hound Partners | 2,500,000 | $2,476,000 | 0.22% |
| DeepCurrents Investment Group LLC | 6,000,000 | $6,117,000 | 0.22% |
| WHITEBOX ADVISORS LLC | 4,000,000 | $3,941,000 | 0.22% |
| Antara Capital LP | 1,500,000 | $1,485,000 | 0.16% |